After surgery, many patients undergo radioactive iodine therapy to destroy any remaining cancer cells
For many patients, particularly those experiencing weight gain related to hormonal changes during perimenopause, andropause, or thyroid dysfunction, combining a GLP-1 or dual agonist medication with hormone therapy can produce better outcomes than either approach alone
Studies in patients with type 2 diabetes and obesity have demonstrated that the use of SGLT2 inhibitors, particularly empagliflozin, not only increases overall cancer risk but also significantly elevates the risk of bladder cancer [10, 108]
The results can be seen after 5-6 sessions, and maintenance sessions help maintain shine
Use alternative drug Acetazolamide + Metformin Acetazolamide increases the toxicity of metformin by others